VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 35 filers reported holding VINCERX PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $393 | -29.1% | 389,512 | -8.7% | 0.00% | -20.0% |
| Q2 2023 | $554 | +36.1% | 426,472 | +8.9% | 0.01% | +66.7% |
| Q1 2023 | $407 | +59.0% | 391,748 | +56.1% | 0.00% | -25.0% |
| Q4 2022 | $256 | -99.9% | 250,995 | +45.7% | 0.00% | +33.3% |
| Q3 2022 | $238,000 | +80.3% | 172,302 | +72.1% | 0.00% | +50.0% |
| Q2 2022 | $132,000 | -61.6% | 100,103 | +461.3% | 0.00% | -60.0% |
| Q1 2021 | $344,000 | – | 17,835 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,658,199 | $2,189,000 | 0.84% |
| Affinity Asset Advisors, LLC | 1,374,098 | $1,814,000 | 0.76% |
| SABBY MANAGEMENT, LLC | 500,559 | $661,000 | 0.45% |
| TANG CAPITAL MANAGEMENT LLC | 1,030,634 | $1,360,000 | 0.21% |
| Rubric Capital Management LP | 2,107,000 | $2,781,000 | 0.15% |
| Long Focus Capital Management, LLC | 980,000 | $1,294,000 | 0.14% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $508,000 | 0.09% |
| Clearline Capital LP | 452,184 | $597,000 | 0.08% |
| Sio Capital Management, LLC | 102,049 | $135,000 | 0.05% |
| Rock Springs Capital Management LP | 814,194 | $1,075,000 | 0.03% |